EFFECT OF SIMVASTATIN THERAPY UPON IMMUNOLOGICAL MARKERS OF ATHEROSCLEROSIS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS

Código QR

EFFECT OF SIMVASTATIN THERAPY UPON IMMUNOLOGICAL MARKERS OF ATHEROSCLEROSIS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS

Аbstract. The study concerned in vitro effects of mevastatin, in”iximab, r-met-Hu-sTNF-RI and IL-1Ra upon antigen-induced activation of EBV-speciлc CD4+T-cells from peripheral blood of the patients with rheumatoid arthritis (RA). RA patients were shown to have signiлcantly lower contents of antigen-...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	I. V. Shirinsky, V. S. Shirinsky
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2014
Materias:	rheumatoid arthritis atherosclerosis immunological markers treatment statins Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/ed25acabc0804b49af3bc88b1b320fa7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

PREDICTION OF CLINICAL EFFICIENCY OF SIMVASTATIN TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

EFFECTS OF STATINS UPON ANTIGEN-SPECIFIC LYMPHOCYTE ACTIVATION IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN IN VITRO STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

СLINICAL EFFICIENCY OF STATINS IN RHEUMATOID ARTHRITIS: A PILOT STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

IN VITRO EFFECTS OF MEVASTATIN AND BIOLOGICAL PREPARATIONS UPON ACTIVATION OF EBV-SPECIFIC CD4+T LYMPHOCYTES FROM THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY
por: I. V. Shirinsky, et al.
Publicado: (2019)

CLINICAL EFFICACY AND SAFETY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONISTS IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL CONTROLLED STUDY
por: V. S. Shirinsky, et al.
Publicado: (2014)

AUTOIMMUNE DISEASES AND ATHEROSCLEROSIS - PROBLEMS OF TREATMENT
por: I. V. Shirinskiy, et al.
Publicado: (2012)

CLINICAL AND IMMUNOLOGICAL PARAMETERS IN EARLY RHEUMATOID ARTHRITIS
por: V. V. Sokolova, et al.
Publicado: (2014)

CULTURES OF FIBROBLAST-LIKE SYNOVIAL CELLS FROM PATIENTS WITH RHEUMATOID ARTHRITIS: PROPERTIES AND OPPORTUNITIES
por: M. A. Schneider, et al.
Publicado: (2016)

INFLUENCE OF HERPES SIMPLEX VIRUS PERSISTENCE UPON PRODUCTION OF CYTOKINES BY IMMUNOCOMPETENT CELLS IN RHEUMATOID ARTHRITIS
por: N. A. Pronina, et al.
Publicado: (2014)

THE PRODUCTION OF PRO- AND ANTIINFLAMMATORY CYTOKINES BY SYNOVIAL FIBROBLASTS OF PATIENTS WITH RHEUMATOID ARTHRITIS IN VITRO WHEN USING DNA METHYLATION MODULATORS - INVESTIGATIVE STUDY
por: M. A. Shnayder, et al.
Publicado: (2019)

PSYCHOPHYSIOLOGICAL AND IMMUNE STATUS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: T. Y. Abramova, et al.
Publicado: (2014)

TELOMERE SHORTENING IN MONOCYTES OF THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: V. I. Borisov, et al.
Publicado: (2014)

STUDIES OF SEVERAL BLOOD CYTOKINES IN PATIENTS WITH RHEUMATOID ARTHRITIS: CLINICAL AND IMMUNOLOGAL INTERRRELATIONS
por: M. V. Pachkunova, et al.
Publicado: (2014)

AUTOANTIBODIES TO CIRTULLINATED ANTIGENS FOR DIAGNOSIS AND PREDICTION OF CLINICAL COURSE IN EARLY RHEUMATOID ARTHRITIS
por: I. B. Belyaeva, et al.
Publicado: (2014)

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
por: Liam J. O’Neil, et al.
Publicado: (2021)

RHEUMATOID ARTHRITIS: LABORATORY MODELS OF THE DISEASE
por: I. A. Orlovskaya, et al.
Publicado: (2015)

Studies of non-autonomous effects of apoptosis in the course of in vitro apoptotic cell death initiation in healthy persons and patients with rheumatoid arthritis
por: T. Ya. Abramova, et al.
Publicado: (2020)

HETEROGENEITY OF POLYCLONAL IMMUNOGLOBULINS NUCLEASE ACTIVITY IN RHEUMATOID AND REACTIVE ARTHRITIS
por: M. V. Volkova, et al.
Publicado: (2017)

Risk of cervical myelopathy in rheumatoid arthritis patients with neck pain
por: Marina W. Gerges, et al.
Publicado: (2022)

Rheumatoid arthritis hand lesions assessed with outcome measures in rheumatoid arthritis clinical trials-rheumatoid arthritis magnetic resonance imaging score – proposing an extended rheumatoid arthritis magnetic resonance imaging score
por: M. del Carmen Larios-Forte, et al.
Publicado: (2021)

PROMOTER POLYMORPHISM -857С>T OF TNFα GENE AND EFFICACY OF ANTICYTOKINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: A. N. Silkov, et al.
Publicado: (2014)

Hyperuricemia Among Egyptian Rheumatoid Arthritis Patients. Is It an Association or an Inflammatory Marker? A Cross-Sectional Observational Study
por: Nada D, et al.
Publicado: (2021)

SUBTYPE CHARACTERICS OF DENDRITIC CELLS FROM PERIPHERAL BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS
por: S. A. Falaleeva, et al.
Publicado: (2014)

Extra‐articular involvement of rheumatoid arthritis in three seropositive patients in the absence of initial joint involvement
por: Razvan M. Chirila, et al.
Publicado: (2021)

Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
por: Jianan Zhao, et al.
Publicado: (2021)

Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
por: Al-Ani N, et al.
Publicado: (2021)

Development of Rheumatoid Arthritis During Anti-Interleukin-5 Therapy in a Patient with Refractory Chronic Eosinophilic Pneumonia
por: Kawabata H, et al.
Publicado: (2021)

COMBINATION ANALYSIS OF CYTOKINE GENE PROMOTER POLYMORPHISMS OF IL1B T-31C, IL-6 G-174C, TNFA G-238A, TNFA G-308A, TNFA C-863A, IL4 C-590T, IL-10 C-592A FOR PREDICTION OF TREATMENT EFFICIENCY IN RHEUMATOID ARTHRITIS
por: V. I. Konenkov, et al.
Publicado: (2014)

ALPHA–2–MACROGLOBULIN COMPLEXES WITH IGG ANTIBODIES, PLASMIN, AND THEIR INTERRELATION WITH OTHER FACTORS OF HUMORAL IMMUNITY DURING THE DEVELOPMENT OF RHEUMATOID ARTHRITIS
por: V. N. Zorina, et al.
Publicado: (2014)

MOLECULAR BIOLOGY ANALYSIS OF IL -1Β, IL -4, AND IL -1Β RA GENE POLYMORPHISMS IN ETHNIC BASHKIR PATIENTS WITH RHEUMATOID ARTHRITIS, LIVING IN C HELYABINSK REGION
por: A. L. Burmistrova, et al.
Publicado: (2014)

Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of Rheumatoid Arthritis Pathogenesis
por: Jianlin Zuo, et al.
Publicado: (2021)

Evaluation of the Health Assessment Questionnaire Disability Index in Chilean patients with rheumatoid arthritis
por: Durán,Josefina, et al.
Publicado: (2019)

Nanotechnology for Targeted Therapy of Atherosclerosis
por: Seyedmehdi Hossaini Nasr, et al.
Publicado: (2021)

INFLUENCE OF DEXAMETHASONE-MODIFIED DENDRITIC CELLS GENERATED WITH IFNα UPON AUTOLOGOUS T LYMPHOCYTE FUNCTIONS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: Yu. D. Kurochkina, et al.
Publicado: (2019)

CLINICAL IMPORTANCE OF DETERMINATION OF HLA-DRB1 LOCUS GENES IN RHEUMATOID ARTHRITIS
por: V. Guseva, et al.
Publicado: (2019)

IN VITRO ACTIVATION OF EARLY-STAGE APOPTOSIS OF T LYMPHOCYTES BY TRANSFERRING APOPTOTIC AUTOLOGOUS CELL CULTURE COMPONENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: T. Ya. Abramova, et al.
Publicado: (2018)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
por: Findeisen KE, et al.
Publicado: (2021)